DiabetesSeriesLive

CME Presentations

Concentrated Insulins


Presentations

  • CME
    1.0

    Concentrated Insulins in Clinical Practice: Pharmacology and Treatment Designs

    Speakers:Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP, Clinical Pharmacist
    Wendy S. Lane, MD, Director of Clinical Research
    Richard Beaser, MD, Senior Physician, Medical Director, Professional Education

    Duration: 60 minutes

    Presented on: June 21, 2017


Speakers

  • Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Alissa Segal, PharmD, RPh, CDE, CDTC, FCCP

    Clinical Pharmacist

    Alissa R. Segal, PharmD, RPh, CDE, CDTC, FCCP is an Associate Professor at MCPHS University and clinical pharmacist at the Joslin Diabetes Center, Boston, MA. After completing post-doctorate residencies at the Medical Center at Princeton and the Medical University of South Carolina, Dr. Segal taught for several years at the University of New Mexico. In 2007, she joined MCPHS University and established clinical pharmacy services at the Joslin. Her research focus on the care of adults with diabetes has led to numerous publications, on diabetes in older adults and concentrated insulin, and book chapters in the Joslin Deskbook, Endocrine and Metabolic Medical Emergencies, and Geriatric Diabetes. She was one of the first pharmacists to receive the Certified Diabetes Technology Clinician certification and is a fellow of the American College of Clinical Pharmacy (ACCP).
  • Wendy S. Lane, MD

    Wendy S. Lane, MD

    Wendy S. Lane, MD

    Director of Clinical Research

    Wendy S. Lane, MD, is a clinical endocrinologist and director of clinical research at the Mountain Diabetes and Endocrine Center in Asheville, North Carolina. Dr Lane has served as principal investigator or sub-investigator for multiple clinical trials for new and investigational oral and injectable medications and insulins for the treatment of type 1 and type 2 diabetes, as well as glucose sensor and insulin pump trials. She has been an author and investigator for several investigator-initiated trials of U-500 insulin via insulin pump and trials involving combinations of GLP-1 receptor agonist therapy with insulin. She was also a contributing author to 2014 AACE Guidelines on Insulin Pump Therapy. Dr Lane earned her medical degree at Dartmouth Medical School in Hanover, New Hampshire.
  • Richard Beaser, MD

    Richard Beaser, MD

    Richard Beaser, MD

    Senior Physician, Medical Director, Professional Education

    Richard S. Beaser, M.D., is a practicing physician in the Joslin Clinic and holds the position of Associate Clinical Professor of Medicine at Harvard Medical School. He has also been the Medical Executive Director of Professional Education at Joslin and was instrumental in developing that activity at Joslin, a department he founded in 1990. Dr. Beaser graduated in 1973 from Trinity College, Hartford, and received his medical degree from Boston University School of Medicine in 1977. He served as a resident in internal medicine at the University of Massachusetts Medical Center in Worcester from 1977-1980. He was a fellow in endocrinology at the Joslin Diabetes Center, Boston, MA 1980-81, and in Endocrinology at the Lahey Clinic Medical Center, Burlington, MA 1981-82. Dr. Beaser has been on the staff of the Joslin Diabetes Center since 1982. He has held numerous past positions at Joslin, including Section Chief of the Adult Diabetology Practice, Medical Director of the Diabetes Treatment Unit, Coordinator of the Patient Education Section, and Medical Director of Joslin TrialNet, a clinical trials network. He has been a clinical research investigator, including the landmark Diabetes Control and Complications Trial. Dr. Beaser has authored 4 books: Joslin Diabetes Manual, Outsmarting Diabetes, The Joslin Guide to Diabetes, and Joslin’s Diabetes Deskbook: A Guide for Primary Care Providers. Dr Beaser is a well-known national lecturer on clinical diabetes and its comorbidities. He is the author of numerous publications in peer review journals, review articles, and book chapters. In his role as Medical Executive Director of Professional Education at Joslin Diabetes Center, and currently as the Chair of the CME Committee, Dr. Beaser has a specific focus on development or oversight of educational content for the department, targeting physicians, other medical professionals, and patients. He leads departmental conceptualization and development of projects and activities.

CME Information

Concentrated Insulins in Clinical Practice: Pharmacology and Treatment Designs

 

Presented by Joslin Diabetes Center in Joint Providership with PlatformQ Health Education, LLC.

ACKNOWLEDGEMENT This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

TUITION Complimentary

ACCREDITATION STATEMENT The activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Joslin Diabetes Center and PlatformQ Health Education, LLC. Joslin Diabetes Center is accredited by the ACCME to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENTS Live Internet Activity Joslin Diabetes Center designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Enduring Material Joslin Diabetes Center designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DATE OF RELEASE/EXPIRATION Live Internet Activity Wednesday, June 21, 2017, from 12:00 PM EST – 1:00 PM EST Enduring Material The enduring material will be available from June 21, 2017 – December 21, 2017.

LEARNING OBJECTIVES At the conclusion of this activity, participants will be able to:

Compare the pharmacokinetic and pharmacodynamic properties of concentrated insulins that are used to treat people with diabetes, particularly those with significant insulin resistance
Recognize the indications for and methods to utilize concentrated insulins to treat type 2 diabetes, including people with significant insulin resistance
Identify barriers preventing the use of concentrated insulins in one's own practice, as well as area primary care practices, and enhance skills in mentoring the use of these treatment tools when indicated
 

INTENDED AUDIENCE Primary Audience: Clinically focused diabetes specialty care providers, including diabetologists, endocrinologists, and internists with a heavy practice focus on diabetes. These providers consist of physicians, nurse practitioners and physician assistants who work in specialty practices. Secondary Audience: Certified diabetes educators and pharmacists with significant numbers of patients/clients with diabetes and non-diabetes specialty physicians who care for a significant number of people with diabetes and insulin resistance and who might be involved in design or management of glycemic control programs, including general internists, cardiologists and nephrologists.

METHOD OF PARTICIPATION There are no fees to participate in this activity. To receive credit, participants must (1) read the target audience, learning objectives, and disclosure statements, (2) complete the educational activity online, and (3) complete the posttest and activity evaluation. It is estimated that this module will take approximately 1 hour to complete. To receive AMA PRA Category 1 Credit™, participants must receive a minimum score of 70% on the posttest.

HARDWARE/SOFTWARE REQUIREMENTS Participants will need a computer with a recent version of Adobe Flash installed, as well as an internet connection sufficient for streaming media.

FINANCIAL DISCLOSURES As part of its accreditation with the Accreditation Council for Continuing Medical Education, Joslin Diabetes Center must disclose to the audience of a Joslin continuing medical education activity the existence of any relevant financial relationships between Joslin and/or its planning and/or CME advisory committee members, speakers, and their spouses/partners and commercial entities. Joslin and its planning and CME advisory committee members and speakers must disclose any relationships they and their spouses/partners have or have had in the prior 12 months with proprietary entities producing healthcare goods or services, with the exception of nonprofit or government organizations and non–healthcare–related companies, which are exempt.

Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fees, honoraria, ownership interests (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit in any amount. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected. If a faculty or planning committee member has no information to disclose, this information will also be provided. If a faculty or planning committee member refuses to disclose, he/she will not be able to participate in the planning, management, presentation, or evaluation of any Joslin Diabetes Center CME activity. In addition, faculty have been asked to disclose when a product or device is not labeled for the use under discussion. The opinions and comments expressed in this program are those of the speakers and should not be considered the opinions or comments of Joslin Diabetes Center. The faculty and planning committee members for this program have disclosed the following:

Faculty

  • Dr. Richard S. Beaser*† , Senior Staff Physician and Medical Director of Professional Education, Joslin Diabetes Center, has no relevant financial relationships with regard to this activity.
  • Alissa Segal, PharmD, CDE† , is on the scientific advisory board for Eli Lilly and Co., Inc. and Boehringer Ingelheim Pharmaceuticals, Inc.
  • Wendy Lane, MD, receives grant / research funding from Novo Nordisk, Inc., Lexicon, Inc., Mylan Pharmaceuticals, DexCom, Inc., and Eli Lilly.

Planning Committee

  • Agnes Yang, MD, Medical Director, PlatformQ Health Education, has no relevant financial relationships.
  • Karen Greb-Murphy, Program Manager, PlatformQ Health Education, has no relevant financial relationships.

Joslin CME Advisory Committee

  • Jerry Cavallerano, OD, Optometrist, Beetham Eye Institute, Joslin Diabetes Center, has no relevant financial relationships.
  • Erin Kelly, CDE, Adult Diabetes Educator, Joslin Diabetes Center, is a contract pump trainer for Medtronic, Tandem, Omnipod and Animas.
  • Melinda Maryniuk, CDE, Director, Clinical Programs, Joslin Diabetes Center, has no relevant financial relationships.
  • Lyle Mitzner, MD, Staff Physician, Joslin Diabetes Center, is a consultant for Conversa Health.
  • Robert C. Stanton, MD, Chief of Nephrology, Joslin Diabetes Center, is a consultant for and receives grant / research funding from Boehringer Ingelheim Pharmaceuticals, Inc.
  • Elena Toschi, MD, Staff Physician, Joslin Diabetes Center, has no relevant financial relationships.

* Also on the Planning Committee † Also on the CME Advisory Committee

CONTACT INFORMATION Please send content inquiries to: cme@joslin.harvard.edu

For technical problems with the site or issues with your CME Certificate, please contact DiabetesSeriesLive at 877-394-1306 or at Support@DiabetesSeriesLive.com.

DISCLAIMERS (if applicable): The material is prepared based on a review of multiple sources of information but is not exhaustive of the subject matter. Therefore, health care professionals and other individuals should review and consider other publications and materials about the subject matter other than relying solely on the information contained in this material.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by Joslin Diabetes Center, DiabetesSeriesLive, PlatformQ Health Education, LLC or the program grantor. Reasonable efforts have been made to present educational subject matter in a balanced, unbiased fashion and in compliance with regulatory requirements. Each participant must use his/her personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.